WebJul 7, 2024 · Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly $40 billion or more, the Wall … WebJun 17, 2024 · June 17 (Reuters) - Drugmaker Merck & Co is considering buying cancer-focused biotech company Seagen Inc , the Wall Street Journal reported on Friday, citing people familiar with the matter.

Merck in advanced talks to buy Seagen in nearly $40-billion deal

WebAug 4, 2024 · Merck has a variety of options besides a full acquisition of Seagen and doing nothing. It can buy Seagen stock, or it can buy into more Seagen drug programs. WebMar 14, 2024 · Pfizer will acquire Seattle-area biotech giant Seagen for $43 billion Biotech experts wary of Pfizer cutting Seagen workforce — but history reveals silver lining Biotech giant Seagen reveals... theramex israel

Seagen With And Without A Merck Buyout - SeekingAlpha

WebJul 7, 2024 · Merck & Co is in advanced talks to buy Seagen in a deal that could value the cancer biotech at $40 billion or more, according to a report Wednesday. WebJun 17, 2024 · Merck is a massive player in the pharma space, with a valuation of more than $200 billion at the time of writing. As it happens, Seagen is no slouch, with a valuation around $30 as of today’s ... Merck has one of the premier oncology franchises in the industry and sells $17 billion of industry-leading cancer drug Keytruda. The drug is approved for at least 14 different types of cancer, and its sales just keep growing. Year-over-year revenue grew 26% in the second quarter. But Keytruda's patents expire in 2028, … See more Rumors have been circulating ever since The Wall Street Journalreported on the potential merger earlier in the summer. But the companies themselves have remained silent, even after the late July verdict in Seagen's lawsuit … See more Merck doesn't necessarily need to own Seagen in order to benefit from its technology. In fact, the two companies already have several ongoing collaborations. The … See more theramex hrt